Hugh A Bialecki, DMD | |
402 S. Grass Valley Rd, Lake Arrowhead, CA 92352-0000 | |
(909) 337-0705 | |
(909) 337-4925 |
Full Name | Hugh A Bialecki |
---|---|
Gender | Male |
Speciality | Dentist - General Practice |
Location | 402 S. Grass Valley Rd, Lake Arrowhead, California |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1093885048 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1223G0001X | Dentist - General Practice | 031570 (California) | Primary |
Mailing Address | Practice Location Address |
---|---|
Hugh A Bialecki, DMD Po Box 275, 402 S. Grass Valley Rd, Blue Jay, CA 92317-0275 Ph: (909) 337-0705 | Hugh A Bialecki, DMD 402 S. Grass Valley Rd, Lake Arrowhead, CA 92352-0000 Ph: (909) 337-0705 |
News Archive
Avedro Inc, a Boston-based ophthalmic medical device and pharmaceutical company announces that it received notification from the U.S. Food and Drug Administration stating that their NDA for riboflavin ophthalmic solution/KXL system has been filed, and has been granted priority review status. The priority review status places the application action date at March 15th, 2014.
Throughout the history of medicine and science, researchers have frequently discovered evidence of promising ways to improve health outcomes for patients and communities - only to have those findings languish in papers published in scientific journals.
In an effort to sign up people for the new health coverage that will become available this fall, Enroll America is one of a number of organizations launching aggressive health law outreach campaigns.
Patients with deadly glioblastomas who received high doses of radiation that hit a portion of the brain that harbors neural stem cells had double the progression-free survival time as patients who had lower doses or no radiation targeting the area, a study from the Radiation Oncology Department at UCLA's Jonsson Comprehensive Cancer Center has found.
Gamida Cell, a leader in cell therapy technologies and products for transplantation and adaptive immune therapy, announced today that orphan drug designation has been granted by The US Department of Health and Human Services, The FDA Office of Orphan Products Development (OOPD) for the investigational medicinal product NiCord for the treatment of acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), Hodgkin lymphoma and myelodysplastic syndrome (MDS).
› Verified 9 days ago
Mr. Corey K Houmand, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 251 N Hwy 173, Lake Arrowhead, CA 92352 Phone: 909-337-6227 | |
Dr. Guy Gerald Giacopuzzi, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 29099 Hospital Road, Suite 208, Lake Arrowhead, CA 92352 Phone: 909-337-9879 | |
Dr. Stephen Dow Barath, D.D.S Dentist Medicare: Not Enrolled in Medicare Practice Location: 28200 Highway 189, Suite 01-250, Lake Arrowhead, CA 92352 Phone: 909-337-4222 |